AbCellera Biologics Inc.

NASDAQ:ABCL

2.4 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 5.056.5077.3239.9549.1796.59910.05612.19221.545101.38345.917316.581139.3315.50827.643202.741207.9089.36211.2284.6573.2023.4512.4792.479
Kosten van de omzet 038.29538.0376.7669.1097.4097.25652.6471.55415.0355.2144.63721.89417.453.6120.0135.7797.4959.1444.1183.3092.7822.0112.011
Brutowinst 5.05-31.788-30.7143.1880.07-0.812.8-40.45519.99186.34840.707271.944117.437-11.94224.033182.731172.1291.8672.0840.539-0.1060.6690.4680.468
Brutowinstmarge 1-4.885-4.1940.320.008-0.1230.278-3.3180.9280.8520.8870.8590.843-2.1680.8690.9010.8280.1990.1860.116-0.0330.1940.1890.189
Onderzoek- en ontwikkelingskosten 46.07640.96940.92739.28748.62237.91736.47352.64728.24526.58226.68526.36617.20917.4515.04612.3528.6367.4959.1444.1183.3092.7822.0112.011
Algemene en administratieve kosten 16.0219.14720.19217.35215.97414.36915.52115.13413.01513.79214.41214.26812.8911.27111.2036.4225.7942.9681.4981.650.9750.7030.5350.535
Verkoop- en marketingkosten 3.1443.1353.1363.3653.13.4683.8413.7712.6913.0893.122.371.8271.2171.2952.5782.2320.6260.5470.4370.4710.2910.250.25
Verkoop-, algemene en administratieve kosten 19.16422.28221.81318.79519.07417.83719.36218.90515.70616.88117.53216.63814.71712.48812.49898.0263.5942.0452.0871.4460.9940.7860.786
Overige kosten 12.56536.91932.156-1.5293.1062.046-1.972.1413.81833.351-1.204-1.354-1.2560.3140.2655.226-2.262-0.293-1.001-0.111000
Bedrijfskosten 77.805100.1762.7458.08271.85658.66156.86973.69257.76946.46347.56841.830.57229.22426.4221.50921.8889.7934.2325.7494.6430.6260.7660.766
Bedrijfsresultaat -72.755-93.663-93.454-54.894-66.053-54.89-51.389-61.5-37.77837.735-6.861224.9581.553-28.096-7.033158.074160.774-1.768-0.854-2.122-1.976-0.716-0.713-0.713
Bedrijfsresultaat ratio -14.407-14.394-12.762-5.515-7.196-8.318-5.11-5.044-1.7530.372-0.1490.7110.585-5.101-0.2540.780.773-0.189-0.076-0.456-0.617-0.207-0.287-0.287
Totaal overige inkomsten en kosten netto 25.92631.03145.26712.14717.45115.61413.38516.7266.3668.8521.515.8593.1573.1244.963.413-4.86-0.9257.5570.0290.3350.7520.410.41
Inkomen voor belasting -46.829-62.632-48.187-42.747-48.602-39.276-38.004-48.148-31.41246.587-6.886230.80984.71-24.972-2.073161.487155.915-2.6936.703-2.093-1.6410.036-0.303-0.303
Inkomen voor belasting ratio -9.273-9.625-6.58-4.294-5.295-5.952-3.779-3.949-1.4580.46-0.150.7290.608-4.534-0.0750.7970.75-0.2880.597-0.449-0.5120.01-0.122-0.122
Belastingkosten -12.619-11.525-11.257-2.137-1.452-10.666-7.476-8.038-1.51919.963-0.10162.23624.762-3.5920.2544.2660.0390000.082000
Nettowinst -34.21-51.107-36.93-40.61-47.15-28.61-30.528-40.11-29.89326.624-6.785168.57359.948-21.38-2.323117.221117-2.6936.703-2.093-1.6410.036-0.303-0.303
Nettowinstmarge -6.774-7.854-5.043-4.08-5.137-4.336-3.036-3.29-1.3870.263-0.1480.5320.43-3.882-0.0840.5780.563-0.2880.597-0.449-0.5120.01-0.122-0.122
WPA (Winst Per Aandeel) -0.12-0.17-0.13-0.14-0.16-0.099-0.11-0.1400.084-0.0240.540.21-0.08-0.0090.430.43-0.010.031-0.01-0.0080-0.002-0.002
Verwaterde WPA -0.12-0.17-0.13-0.14-0.16-0.099-0.11-0.1400.084-0.0240.540.21-0.077-0.0090.370.37-0.010.028-0.009-0.0070-0.002-0.002
EBITDA -55.311-51.877-56.932-48.128-58.517-44.653-39.557-59.36-4.66453.315-0.845235.78294.798-20.7662.142165.453162.3040.5068.076-0.446-1.061-0.326-0.318-0.318
EBITDA ratio -10.953-7.972-7.568-4.835-5.836-6.767-3.934-4.46-0.2160.46-0.0180.7430.676-3.5420.0660.8150.7810.0540.719-0.096-0.281-0.094-0.128-0.128